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Measuring health sciences research capacity and performance in Africa: mapping the available data 
 
Abstract 
Background: In recent years there have been calls to strengthen health sciences research capacity in African 
countries. This capacity can contribute to improvements in health, social welfare and poverty reduction 
through domestic application of research findings; it is increasingly seen as critical to pandemic 
preparedness and response. Developing research infrastructure and performance may reduce national 
economies’ reliance on primary commodity and agricultural production, as countries strive to develop 
knowledge-based economies to help drive macroeconomic growth. Yet efforts to date to understand health 
sciences research capacity have focused primarily on output metrics, such as journal citations and 
publications. 
Methods: We mapped and assessed current capacity for health sciences research across all 54 countries of 
Africa by collecting a range of available data. This included structural indicators (research institutions and 
research funding), process indicators (clinical trial infrastructures, intellectual property rights and 
regulatory capacities) and output indicators (publications and citations).  
Results: While there were some countries which performed well across the range of indicators used, for 
most countries the results were varied – suggesting high relative performance in some indicators, but lower 
in others. In many countries, there were missing data for key measures of capacity or performance.  
Conclusion: Taken as a whole, the existing data suggest a nuanced view of current health sciences research 
landscape on the African continent. Mapping existing data may enable governments and international 
organisations to identify gaps in health sciences research capacity, particularly in comparison to other 
countries in the region. It also highlights gaps where more data are needed. These data can help to inform 
investment priorities and future system needs. 







Health sciences research (HSciR) has been defined to include basic, clinical andapplied science on human 
health and wellbeing, as well as the determinants, prevention, detection, treatment and management of 
disease.(1–3) To date, the majority of HSciR has taken place in the global north.(4–6) As of 2018, less than 
1% of scientific articles published worldwide each year include at least one author based at an African 
institution.(7) 
In the past few years, however, a number of international organizations, including the African Union (8), 
World Health Organization (9) and World Bank (10), have called for political and economic investment in 
HSciR in Africa. Several high-profile reports have further raised awareness of the so-called 10/90 gap: only 
a tenth of global expenditure on health research is targeted to issues that affect the poorest 90% of the 
world’s population.(5)  
There are two key reasons why investments in HSciR in Africa may be particularly important from a 
developmental perspective. First, the promotion of a strong health science industry, as part of broader 
efforts to establish a robust research and development landscape, can contribute to development goals by 
reducing national economies’ reliance on primary commodity and agricultural production; this can help 
governments develop knowledge-based economies, which may be important for macroeconomic 
growth.(11–15) In a seminal 1990 report, the Commission on Health Research and Development (4) stated 
that strengthening research capacity in low- and middle- income countries (LMICs) is “one of the most 
powerful, cost-effective and sustainable means of advancing health and development” (p.71).  
Second, HSciR may contribute to improvements in health, social welfare and poverty reduction through 
domestic application of the findings of the research itself.(16–18) The 2013 World Health Report stressed 
that all nations should be producers, users and consumers of HSciR.(6) Africa is home to nearly one-sixth 
of the world’s population and is estimated to account for about a quarter of the global burden of disease.(19) 
Yet only a small fraction of global health research currently focuses on diseases which exclusively affect 
LMICs.(20,21) While there have been developments in the HSciR landscape over the past three decades, 
many LMICs have been unable to build up sufficient capacity to develop their own evidence base nationally 
to inform policy directly and/or to improve their population’s health.(22–24) The International Vaccines 
Task Force of the World Bank has highlighted the importance of building research capacity to lower the 
risk of emergent epidemics.(25) 
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To date, few academic studies have evaluated HSciR capacity in LMICs. The most widely available 
indicator of health research capacity is the publication of health-related scientific journal articles. These 
have been the focus of research in the past, with bibliometric analyses undertaken to map the numbers of 
African publications related to cardiovascular diseases (26,27), genomics (28), health economic evaluation 
(29), health policies and systems (30,31), human immunodeficiency virus (32), neglected tropical diseases 
(33) and public health.(34) Four studies have also examined the total number of African publications on 
any health-related topic (as indexed in major bibliographic databases).(35–38) Beyond publication outputs, 
however, researchers have also collected data on investments in health-related research and development 
(R&D) (35), clinical trial infrastructures (25,35), healthcare workforce numbers (39) and the numbers of 
universities and ‘centres of excellence’ (39,40) in African countries to estimate HSciR capacity. 
Each of these studies can help to understand individual aspects of HSciR capacity in African countries, yet 
no single piece of information can fully capture the degree of capacity in a country or region. There remains 
a need for analyses which attempt to collect and analytically combine data on multiple indicators to provide 
a more comprehensive analysis of HSciR capacity across the continent.  
2 Background 
2.1 The importance of knowledge economies  
Science and innovation, if well-utilized, may play a core role in realizing sustainable development.(1,41) 
As seen from the experiences of many industrialized nations, scientific research and linked innovations 
have been core to economic and social advancement over the past two centuries – be it medical innovations 
such as vaccines and antibiotics, or industrial innovations in manufacturing, communications and 
computation.(42–44) 
More recently, questions have been asked as to whether scientific research supports development, or 
whether it represents a product of development.(45,46) Both these positions have their justifications. In 
terms of science resulting in development, it is research and knowledge generation, linked with subsequent 
innovation and application of that knowledge, that some argue has been critical to overcoming key 
development challenges in LMICs.(45) Under this position, the need to invest in capacity for mobilizing 
and using science and innovation can be viewed as an essential component of strategies for promoting 
sustainable development.(47–49) This argument appears to underpin the inclusion of research within the 
Sustainable Development Goals. Goal 3.B specifically focusses on health research for LMIC needs, calling 
for “supporting the development of research and development of vaccines and medicines for health 
conditions which affect LMICS”; goals 9.5 and 12.A call for increased scientific, technical and research 
capacity more generally in developing countries.(50)
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Many calls for the creation of so-called ‘knowledge economies’ are linked to thinking of research activity 
as an end goal of development. It has been argued that the conceptualization of an economy of knowledge 
reproduces a growth and market-oriented rationale for knowledge production, accumulation and diffusion 
which has particularly influenced the international aid, education and development agenda.(51,52) For 
example, the OECD(11) defines knowledge-based economies as those “which are directly based on the 
production, distribution and use of knowledge and information’’ (p. 7). The World Bank has classified the 
knowledge economy into four areas: economic and institutional regime, education and skills, information 
and communication infrastructure and an innovation system – with the agency going so far as to create a 
Knowledge Economy Index (KEI) as an indicator of a country’s ‘preparedness’ for a knowledge 
economy.(53)  
Asongu and colleagues(54) found the overall trends in African countries’ performance between 1996 and 
2010 differed across the World Bank’s KEI dimensions: Tunisia led in education, the Seychelles in 
information and communication technology, South Africa in innovation and Botswana and Mauritius in 
institutional regime. Oluwatobi and colleagues(55) have argued that the potential for knowledge production 
and innovation in Sub-Saharan Africa is mitigated by the level of human capital and quality of institutions. 
Overall, quality education and strong institutions are held to be imperative for the transformation into a 
knowledge economy.(55–57) Both educational and economic institutions may create enabling structures 
for developing knowledge and innovation and for economic growth, but their influence varies according to 
institutional arrangements, income and development levels in countries.(57–59) In particular, education 
plays a vital role in strengthening human capital, which directly influences the ability to create, absorb, 
transform, disseminate and use knowledge and innovation.(55,60–62) Education and training emphasizing 
the value of traditional knowledge and culture also strengthens human capital to innovate contextually 
relevant solutions for local development problems.(54,59,63)  
2.2 The contribution of health sciences research 
Within the broader remit of science for development, HSciR is vital in its own specific way. Health research 
has led to collective human benefit, development of medical treatments, or better understanding of health 
risks of activities such as tobacco smoking. At a national level HSciR can also specifically generate 
evidence that is useful for public service planning and program implementation. It can provide policy-
relevant information, including disease trends, risk factors, outcomes of interventions, patterns of care, as 
well as health systems and services costs and outcomes.(64) 
Grant and Buxton developed a framework to estimate the value that HSciR provides to countries.(65) Their 
analysis has included as benefits reduced expenditure on delivering existing services; service and provision 
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delivery improvements; health service effectiveness improvements; greater overall improvements in health 
and equity with more consideration of allocation of resources and access to provision and a healthy, 
performance driven workforce. 
 
Finally, Dobrow et al. have shown that HSciR evidence can in turn support development of the process of 
health policymaking through the identification of new issues worthy of bringing to the policy agenda in a 
particular context, supporting decision-makers in their analyses of policy content and continued direction 
and policy impact monitoring and evaluation(66); Gilson has noted that health policy and systems research 
more specifically provides insights into how policy decisions are made and the factors affecting successful 
policy implementation.(67) In many ways, these examples capture the benefits widely seen to follow from 
a system of evidence-informed policymaking, whereby a more systematic and robust use of research 
evidence in decision making is seen to improve planning effectiveness efficiency and policy 
implementation to serve the broader social good.(16,68)      
HSciR input and output by national governments are not uniform, with significant disparities between 
regions or income levels and also across countries within the same region or at similar levels of 
income.(69,70) On the African continent, for example, Tanzania and Lesotho had similar levels of GDP 
per capita (USD 2,365 and USD 2,494, respectively, in 2013); however, the percentage of GDP invested in 
research in Tanzania was more than 3 times higher than in Lesotho (0.28 v. 0.08) while the number of 
publications per million inhabitants was nearly 50 times higher, at 770 in Tanzania compared to 16 in 
Lesotho.(71)  
One of the most critical contextual determinants of HSciR outputs is historical evolution of research 
systems. For those African nations subject to colonial rule, for instance, modern forms of research were 
often developed in service to the economic interests of the colonising power. The focus of research thus 
centred on key exports such as agriculture, forestry and mining related activity, with little interest in HSciR 
to benefit local populations.(72,73) After independence, HSciR remained embryonic, with governments 
often choosing to invest in economies based on the commercialisation of cash products and natural 
resources rather than in the development of research and technology.(74) Moreover, countries which have 
experienced conflict, instability and other socio-political crises, have had to direct resources towards 
reconstruction and peacekeeping investments, rather than towards scientific research and innovation.(75)  
For some nations, the catalyst for investment and development of HSciR has mainly been through the 
emergence of health crises—new diseases such as HIV/AIDS and Ebola, or the rising incidence of 
tuberculosis and plague.(76,77) (MTN, 2017). Outbreaks have also at times inspired new policies calling 
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for investment in HSciR  by global organisations such as the World Health Organization (WHO) and 
UNESCO.(78,79) These calls for investment have allowed for a more open dialogue and progress on 
conceptualising the importance of health research, even within low-income African states—with several 
governments now committed to investing in scientific research in connection with a country's economic 
and sustainable development priorities.(80–82) Despite these shifts, such as the Bamako initiative: WHO’s 
efforts to regionalise research efforts and signs of increased attention to domestic HSciR, key drivers of 
research and research funding in the health sector remain exogenous to African states. Indeed, funding 
largely reflects global HSciR priorities, with limited options for investigator-initiated research on local 
health concerns.    
2.3 How to measure health sciences research? 
 
While there is a strong case that HSciR in LMICs is important at national and global levels – for improving 
health, preventing epidemic spread, supporting health policy and systems and as an influential factor of 
national development more broadly – there is no single framework or consensus method to assess HSciR 
capacity across countries. Indicators for measuring and monitoring HSciR generally include standard output 
indicators of knowledge production and innovation, such as scientific journal articles per million inhabitants 
or patents per million inhabitants (53) and input and process indicators of health research and development. 
Such process indicators can include gross domestic research and development expenditure on health as a 
percentage of GDP, number of clinical trials per million inhabitants, research grants and full-time 
equivalent health researcher per million inhabitants.(35) From the perspective of decision-makers in 
national agencies, these indicators of knowledge production and human resources for research are helpful 
for benchmarking performance against regional and global comparators and for informing policy and 
strategy to strengthen research and development.(83)  
Researchers and international organisations have attempted to compile indicators and measure HSciR 
capacity in different ways. For example, the WHO has created a Global Observatory on Health Research 
and Development which aims to “consolidate, monitor and analyse relevant information on health research 
and development activities”.(84)  This uses a logic model perspective to assessing HSciR, tracking a range 
of indicators to monitor health R&D inputs, processes and outputs as identified and defined by Røttingen 
and colleagues.(35) While these indicators are useful for monitoring and benchmarking the state of HSciR 
and development activities, funding and performance at the national level, they do not provide information 
to assess overall capacity of national health research systems as a set of “people, institutions and processes” 
for HSciR.(4) Moreover, there are incomplete or missing data for many of these indicators. 
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A second approach takes a systems perspective to assessing HSciR capacity, recognising that R&D funds 
and personnel represent but two components of a nation’s HSciR capacity. Pang and colleagues(17) defined 
a national health research system within a conceptual framework considering four key tenets: stewardship, 
financing, creating and sustaining resources and producing and using research. This framework has been 
operationalised under the Research for Health unit at the WHO Regional Office for Africa through the 
development of a “Barometer” that aims to assess the evolution of national health research systems. The 
team collect data from surveys of individual health research focal points in countries (with rounds in 2003, 
2009, 2014 and 2018).(85–89) Key informants within national Ministries of Health and other institutions 
replied to questions about whether HSciR policies, institutions, or other resources were currently in place 
in the country (e.g. national health research policy, national research ethics committee, national health 
research institute, national budget line for health research)(85).  
In applying this approach, Kirigia and colleagues(86) analysed trends between 2003 and 2014 to show that 
although there have been positive gains across many functions, there are still considerable gaps in many 
African countries. For example, in Sub-Saharan Africa, fewer than 50% of countries have an nationwide 
official health research policy, nor a national health research strategy/policy plan, a HSciR law or 
regulation, nor a much needed budget line for HSciR within the Ministry of Health. Approximately half of 
states analysed have a national health research institute/council, a  research programme at the governmental 
level, or an equivalent health research management forum. Public financing for HSciR is also typically 
measured to be very low, with minimal progress towards the goal of 2% of the national health expenditure 
allocated to HSciR. Instead, most funds for HSciR come from external sources such as international 
organisations, NGOs, or multilateral/bilateral partners. According to Kirigia et al, the weakest elements of 
African health research systems are human resources for HSciR, government spending on HSciR, 
publications in peer-reviewed journals and research institutions to conduct HSciR.(87) 
Overall, there have been a variety of attempts to identify key elements of HSciR activity, performance and 
capacity in Africa. Some have assessed R&D potential, measured funding inputs, or identified gaps in 
national HSciR systems. These efforts shed light on where strengths and weaknesses lie, but currently do 
not provide a comprehensive review and synthesis of data on which to comparatively evaluate HSciR 
knowledge and innovation, HSciR and development activities and HSciR systems at the national level 
across Africa.  
The aim of this paper is to build on earlier work by collecting and aggregating data on a range of variables 
to consider HSciR activity, performance and capacity in all African countries. We develop a framework for 
evaluating a country’s capacity for HSciR based on publicly available global data sources. This framework 
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incorporates and expands on indicators from previous studies. Using this framework, we present data on 
HSciR capacity in each of the 54 UN-recognised African states to map current capacity across the region 
for health sciences research – providing one of the first analyses to systematically outline the contribution 
of African countries to HSciR across such a wide range of indicators.  
3 Methods 
3.1 Data collection 
We reviewed data for each of the 54 UN-recognised states in Africa. This excluded any foreign departments 
(e.g., Mayotte), regions (e.g., Réunion), or territories (e.g., Saint Helena) located in Africa, as well as the 
disputed territory of Western Sahara. We collected population and gross domestic product (GDP) data from 
the World Bank(90) for each of these states to be able to benchmark our findings against broader 
development metrics. 
We sought to identify a range of indicators which could help measure the HSciR capacity in each country. 
We used the indicators selected by the World Health Organization Global Observatory on Health R&D 
database as a starting point, which comprised gross expenditure on R&D (GERD) as a proportion of GDP, 
health researchers per million inhabitants, number of institutions and official development assistance for 
the medical research and basic health sectors as a proportion of gross national income.(91) We then 
supplemented this with others measures of HSciR capacity which we identified through discussions 
between authors and members of a project oversight committee1, including bibliographic data, data on 
clinical trial infrastructures, regulatory environment, intellectual property rights and research funding. All 
data were acquired between June and September 2018. 
To classify and conceptualise the various indicators available, we followed the Donabedian(92) model of 
health care quality measurement to categorise our indicators into one of three types: structural, process and 
output measures related to HSciR. Structural measures capture inputs into the system and thus comprised 
metrics such as workforce numbers, budget allocation to R&D and numbers of organisations, regulations 
and guidelines on human subject protections. Process measures are indicators of ongoing HSciR activities, 
including numbers of clinical trials registered and patent applications. Finally, output measures capture the 
outputs of research activities including numbers of peer-reviewed publications and citations for these 
publications.  
 
1 This project oversight group was comprised of a funders, researchers and policy officers based in Kenya, Ghana, 
South Africa, USA and UK and convened by Wellcome Trust.  
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3.2 Structural Indicators  
1. R&D expenditures and personnel  
Data on R&D expenditure and personnel were obtained from the United Nations Educational, Scientific 
and Cultural Organization (UNESCO) (2016, or the most recent available year).(91) We collected data on 
the number of full-time equivalent staff in the following categories: (i) R&D personnel (per million 
inhabitants), (ii) researchers (per million inhabitants) and (iii) researchers with doctoral or equivalent 
degrees (as a proportion of total number of researchers). From the same database, we also collected data on 
gross domestic expenditure on R&D in current purchasing power parity (PPP) dollars (in thousands); these 
figures were also shown as a proportion of GDP and per capita. Whenever possible, we collected 
expenditure and personnel data specific to medical and health sciences. 
2. Research institutions 
We collected data on the number of universities in each country, using a list based on information from the 
International Association of Universities.(93) We recognise that there may be limitations affecting the 
quality of data from this source, thus, we also identified the number of African universities listed on the 
most recent global university rankings of three influential publishers: Quacquarelli Symonds Limited (QS 
World University Rankings) (94), Times Higher Education (THE World University Rankings) (95) and 
Shanghai Ranking Consultancy (Academic Ranking of World Universities).(96) Whilst this may not be 
comprehensive, it allows an indication of the number of institutions across the continent.  
We further collected data on the number of institutional review boards(97) and WHO Collaborating 
Centres(98) in each country and noted whether or not there exists a national ethics committee(99) and 
national public health institute.(100) 
3. Research funding 
We collected data on international funding awarded to researchers in each country (2008-2017) from the 
ten largest public and philanthropic funders of health research globally (listed in order of size)(101): (1) 
U.S. National Institutes of Health, (2) European Commission, (3) U.K. Medical Research Council, (4) 
French National Institute of Health and Medical Research, (5) U.S. Department of Defense (including the 
Congressionally Directed Medical Research Program), (6) Wellcome Trust, (7) Canadian Institutes of 
Health Research, (8) Australian National Health and Medical Research Council, (9) Howard Hughes 
Medical Institute and (10) German Research Foundation. 
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The data were collected from each funder’s website. As we are seeking to understand current capacity, we 
only counted funding allocated to researchers based at institutions in African countries. We excluded 
funding for research projects in which the principal investigators were based at non-African institutions, 
even if these projects included collaborators, field sites, or locations of research in Africa. 
Foreign currencies were converted to dollars based on the yearly average exchange rates published by the 
World Bank.(90) All amounts were reported in 2018 U.S. dollars based on the U.S. consumer price index 
adjustments to account for inflation.  
3.3 Process Indicators (clinical trial infrastructures, intellectual property rights and regulatory capacities) 
Data on the numbers of clinical trials and records, as of 4 August 2018, were extracted from the WHO 
International Clinical Trials Registry Platform (ICTRP)(102) and US National Institutes of Health database 
(ClinicalTrials.gov).(103) ClinicalTrials.gov indexes trials of new investigational drugs, whereas the 
ICTRP indexes data from several sources, including the European Union Clinical Trials Register, 
ClinicalTrials.gov, International Standard Randomised Controlled Trial Number register and Pan African 
Clinical Trial Registry. A full list of data providers can be found on the ICTRP website.(102) The ICTRP 
registry accepts all types of clinical research studies, including trials of public health interventions. 
We also collected information on the number of organisations, regulations and guidelines on human 
subjects protection in each country. These data, which are collected annually by the US Department of 
Health and Human Services (104), reflect protections in each of the following categories: “general (ie, 
applicable to most or all types of human subjects research)”, “drugs and devices”, “clinical trial registries”, 
“research injury”, “social-behavioural research”, “privacy/data protection”, “human biological materials”, 
“genetic” and “embryos, stem cells and cloning”. We used the 2018 edition of the compilation of 
protections.(104) 
Finally, we collected data from the World Intellectual Property Organization on the numbers of patents 
issued to residents in each country (2016, or most recent available year).(105) 
3.4 Output Indicators (publications and citations) 
To systematically collect publication data, we searched Scopus, largest global peer-reviewed literature 
abstract and citation database.(106) Scopus was chosen as it includes a larger volume of non-English 
language journals than many other major bibliographic databases (e.g. Web of Science or 
PubMed/Medline).(106) We searched for any articles published in the following Scopus subject areas: 
health sciences (medicine, nursing, veterinary, dentistry, health professions) and life sciences (agricultural 
and biological sciences, biochemistry, genetics and molecular biology, immunology and microbiology, 
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neuroscience and pharmacology, toxicology and pharmaceutics). We included the following types of 
publications: articles, in press, books, chapters and conference papers. 
We searched for articles published with at least one author based at an institution in each of the 54 countries, 
using the “Affiliation country” field in Scopus. We searched the names of each country in English, French 
and Portuguese, as well as variant spellings of country names. We restricted the searches to publications 
published in the ten-year period from 2008 to 2017. The search strategy, including the country names, can 
be found in Appendix 1. 
For each country, we extracted data on the number of publications with at least one author based in the 
country, as well as the number of publications first authored by a local researcher. We also collected citation 
data for all articles. For publications published in the five-year period from 2013 to 2017, we collected data 
on the proportion of publications with international, institutional and national collaborators; these data were 
unavailable for articles published before 2013. These data were obtained in SciVal, a research information 
tool developed by Elsevier to synthesise bibliometric data from Scopus. 
 
4 Results 
Data for each individual indicator are presented as a series of tables in Appendix 2. We describe findings 
for each indicator below, before providing a summary table in this section (see Table 1). 
Appendix 2: Table 1 presents the bibliometric data collected in Scopus and SciVal. The total number of 
outputs (with at least one author from an African state) published between 2008 and 2017 ranged from 25 
in São Tomé and Príncipe to 63,171 in South Africa. On a per-capita basis, the Seychelles had 3,568 
publications per thousand population, while South Sudan had only 0.007 publications per thousand people. 
The absolute number of citations for published outputs ranged from 335 in São Tomé and Príncipe to 
243,026 in Kenya.2 Three quarters (43/54) of country publications included international authors, yet a 
small share of total publications was first authored by researchers based in each country.   
Appendix 2: Table 2 shows the data on clinical trial infrastructures and intellectual property rights. The 
number of clinical trials indexed in the World Health Organization’s International Clinical Trials Registry 
Platform ranged from 0 in Cape Verde to 4,341 in South Africa. On a per capita basis, South Africa also 
had the highest number of registered trials (77.5 per million population) and some regional differences 
could be seen. In general Anglophone Eastern and Southern African nations appeared to have more trials 
 
2 No citation or first-author publication data were retrievable for South Africa or Egypt 
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per capita than many Francophone African countries, although Guinea Bissau and The Gambia stand out 
as having significantly more trials per capita to other surrounding countries. The number of patent 
applications by residents (2016, or last available year) ranged from 1 in Botswana, Djibouti and Tanzania 
to 2,783 in South Africa. Per capita, the highest number of patents filed South Africa, followed by Tunisia 
and Egypt – three of the higher income countries in the region. However, these were followed by Sudan as 
the fourth most prolific patent producer, despite a much lower income level. 
Appendix 2: Tables 3 and 4 present R&D personnel and spending, respectively. Based on data from 2016, 
or the nearest available year, the number of researchers per million inhabitants ranged from 7 in the 
Democratic Republic of Congo to 1,965 in Tunisia; the proportion of researchers with doctoral or equivalent 
degrees ranged from 10% in Malawi to 72% in Cape Verde. The gross expenditure on R&D as a share of 
GDP ranged from 0.01% in Madagascar to 0.8% in South Africa. The proportion of gross expenditure on 
R&D that went to the medical and health sciences ranged from 0% in Lesotho to 30% in Swaziland. 
Appendix 2: Table 5 presents data on regulatory capacities. About half the countries had a national public 
health institute (27/54) and national ethics committee (25/54). The number of institutional review boards 
ranged from 0 in several countries to 30 in South Africa.  
Appendix 2: Table 6 shows the amount of funding awarded to researchers in each country (2008-2017) 
from ten large organisations. These data indicated only 29 countries receiving funding from these 
organisations, apparently leaving 25 others without any research funded by the ten largest research funders. 
Some funding bodies spread resources widely across countries, such as the US National Institutes of Health, 
while others like the UK Medical Research Council appeared to focus on just a few countries (with more 
than half of its research expenditure in Africa going to the Gambia, according to data obtained).  
Table 1 below presents data for selected indicators. We have shaded each cell to reflect whether the data 
in that cell falls in the highest, middle, or lowest tercile of the range, with green for the top tercile, yellow 
the middle and orange the bottom. The table shows that while there were some high-achievers across the 
board, the results were varied for most states – suggesting high relative performance in some indicators, 
but lower in others (or missing data). For example, Libya was a relatively high achiever for publications, 
first author publications and number of research institutions, but lagged behind this success with the number 
of clinical trials conducted within the country. Conversely, Burundi had low numbers of publications, first 
author publications, number of clinical trials and GERD as a % of GDP, but performed relatively well in 
number of research institutions. While many of the higher income countries unsurprisingly perhaps do well 
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Algeria  159,049   40,606   3,917   198.07   159.41   4.06   0.76   0.06604   7.2459   220   168.0163   16.2167   
Angola  95,335   28,813   3,309   15.48   4.16   0.56   0.59         84   47.48423   20.08696   
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Djibouti  1,727   942   1,833   64.73   31.84   4.24   1.06                  





10,685   1,221   8,747   93.33   9.82   4.91   0.82                  
Eritrea  2,608   4,475   583   34.42   12.07   1.34   0.22                  
Ethiopia  72,374   102,403   707   96.93   64.74   1.84   0.30   0.60474   8.29691   121   44.96602   
16.65635 
  
Gabon  14,214   1,980   7,179   607.64   225.28   31.82   1.01   0.57924   83.1039            
Gambia  965   2,039   473   576.40   178.07   58.38   1.47   0.13309   2.02923   603   33.55545   55.6314   
Ghana  42,690   28,207   1,513   248.34   130.50   8.44   0.92   0.37655   11.28715   123   38.37288   
34.39294 
  
Guinea  8,200   12,396   662   124.80   33.72   2.50   0.32                  
Guinea-
Bissau  
1,165   1,816   642   183.40   61.13   34.15   N/A                  
Ivory Coast  36,373   23,696   1,535   110.65   66.38   3.04   0.30            69.20697      
Kenya  70,529   48,462   1,455   294.79   125.27   13.19   1.03   0.78578   19.06104   1029   225.0294   6.072   
Lesotho  2,291   2,204   1,040   84.40   29.04   9.98   0.45   0.04804   1.38796   33   22.83131   28.0597   
Liberia  2,101   4,614   455   55.92   9.75   5.42   0.22                  
Libya  34,699   6,293   5,514   240.42   116.79   3.02   1.91                  
Madagascar
  
10,001   24,895   402   80.30   27.32   1.08   0.24   0.01498   0.226   113   24.7042   
46.99187 
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Mali  14,035   17,995   780   93.97   27.51   9.45   0.06   0.31461   6.44217   73   30.79076   61.79232   
Mauritania  4,739   4,301   1,102   52.78   19.30   2.33   0.23                  
Mauritius  12,168   1,263   9,631   583.31   319.75   26.91   1.58   0.17773   31.00158   500   181.82964   27.58227   
Morocco  103,606   35,277   2,937   341.61   269.70   5.41   0.79   0.71454   45.77682   1149   1068.96019   16.23857   
Mozambiqu
e  
11,015   28,829   382   60.04   18.80   3.36   0.55   0.33751   4.02668   83   41.47952   13.9878   
Namibia  10,948   2,480   4,415   413.76   135.90   2.82   1.61   0.33996   34.44063   236   143.31554   21.76018   
Niger  7,528   20,673   364   38.89   13.45   1.64   0.05         44   7.41641      
Nigeria  404,653   185,990   2,176   166.80   139.00   1.84   0.65   0.21896   9.38995   77   38.7694   34.11257   
Republic of 
the Congo  
7,834   5,126   1,528   179.68   68.48   10.14   0.20         67   31.54328      




343   200   1,715   125.06   20.01   10.00   N/A                  
Senegal  14,684   15,412   953   237.94   114.13   6.68   0.65   0.75183   18.4002   623   549.32251   38.68145   
Seychelles  1,427   95   15,075   3580.48   602.03   31.69   21.12   0.2214   63.26424   2028   146.48878   15.38462   
Sierra 
Leone  
3,737   7,396   505   71.66   13.79   5.27   0.41                  
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South 
Africa  
295,456   56,015   5,275   1127.74   N/A   77.50   0.45   0.79848   105.3203   743   473.12028   35.21929   
South 
Sudan  
9,015   12,231   737   0.00   0.00   0.16   0.25                  
Sudan   95,584   39,579   2,415   93.31   49.67   1.79   0.96   0.29844   9.09993            
Swaziland   3,721   1,343   2,770   403.54   148.16   16.38   0.74   0.27013   22.36062   309   119.14495   24.98067   
Tanzania   47,340   55,572   852   138.85   56.99   7.79   0.40   0.52924   12.31825   39   18.33753   32.78053   
Togo   4,400   7,606   578   121.48   73.89   2.10   0.13   0.27166   3.76403   42   31.76941   68.88061   
Tunisia   42,063   11,403   3,689   1800.54   1502.90   37.36   1.67   0.59989   69.69501   2069   1964.96647   35.06687   
Uganda   24,079   41,488   580   198.85   84.27   15.69   0.46   0.17043   2.93947   42   26.46695   30.51177   
Zambia   21,064   16,591   1,270   166.23   51.89   15.79   0.48   0.27819   7.7016   163   40.97071      
Zimbabwe   16,620   16,150   1,029   186.06   81.73   11.76   0.93         118   88.72377   13.45285   
                                       
   
* Except Djibouti (2015), 
Eritrea (2011), Libya (2011) 
and South Sudan (2015)   
Source: World Bank   
** Except Eritrea (2011)   
Source: World Bank   
   
Note: put two N/A (South 
Africa and Egypt) as highest 
category   
   
Note: put two 
N/A as lowest 
category   








Appendix 2 presents a further set of 10 figures—to illustrate associations between various metrics and 
GDP (gross and per capita). In general, there was a strong positive association between GDP and the various 
indicators collected. However, there could be significant spread around the linear trend lines plotted, 
indicating some countries performing particularly well or poorly relative to income level.  
 
4.1 Limitations  
This study has limitations. First, there is no single indicator for accurately ascertaining HSciR. Accordingly, 
we used a variety of available metrics that serve as proxy indicators. Thus, there is a risk that these proxies 
do not capture the full landscape we sought to map. For example, we have not accounted for broader 
financing and infrastructure which contributes to HSciR – such as buildings, routine access to electricity 
and primary and secondary education attainment. Each of these may contribute to a country’s capacity for 
HSciR, but they may be part of broader development measures.  Such indicators may not clearly 
demonstrate impact of HSciR and can be difficult to disaggregate. However, there is support for the 
indicators we selected for our framework from the literature discussing measurement of health R&D 
globally and in Africa.(35,107) Nevertheless, we acknowledge that there are multiple challenges and issues 
with measuring HSciR performance using universal indicators in the contexts of African national health 
research systems.(108)    
Second, there are some important limitations of the sources of data used. Given the lack of consistent data 
collected and reported at national levels in HSciR, or indeed at the regional level, we restricted our searches 
to global level data sets to try to ensure some degree of comparability. This approach fails to take into 
account the reality of what might be occurring within countries which is not reported formally, or not 
published at the national, regional or global level.  Moreover, at the global level there was a lack of data for 
several indicators, or these data were outdated. The most comprehensive data sources were for publications 
and clinical trials, but many other indicators were missing results for numerous countries. In some data 
categories, there were issues of reliability and comparability between sources. Furthermore, while we aimed 
to collect data from 2007-2017, some data points had to come from before this time frame when more recent 
data were not available. This included data on patent applications and human resources. Ultimately, we 
decided that including data outside the period was better to get a fuller picture of the HSciR landscape.  
Third, for the output indicators, it is important to note that research outputs are not always published in 
peer-reviewed journals and therefore limiting the analysis to bibliometrics from SciVal could have led us 
to outputs in other sources and formats. Our approach does not include research published outside of peer-
reviewed journals, including government or non-governmental literature policy reports, open data sets, 
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software, or other grey literature. Scopus also does not index all journals published in African states. . 
Similarly, we recognise that for the structural indicators, we only included universities, which may provide 
an incomplete picture of  key research structures and institutions within a country. . While the presence of 
universities was felt to be a reasonably comparable metric to serve as a proxy for infrastructure capacity, it 
is known that there are very important contributors to the HSciR landscape in Africa that are not affiliated 
to a specific university per se – e.g., Tanzania’s Ifakara Health Institute, the Kenya Medical Research 
Institute and the African Population and Health Research Centre (APHRC). These entities undertake a large 
amount of work at national or regional levels. Indeed, some centres of excellence in Africa may be 
undertaking a very large share of HSciR in a given country, and not be affiliated with a university. While 
the activities of such organisations might be captured in publication metrics or clinical trials data, future 
efforts to evaluate HSciR capacity may need to consider ways to identify, count, or compare the importance 
of centres of excellence as core hubs of institutional capacity.(109) 
Fourth, we were unable to find a consistent data source across the African continent to measure government 
budget allocation to HSciR. Instead, we used GERD as a proxy, which (see Table 1 above) captures 
investments in R&D (although not disaggregated by health sciences). Furthermore, data on GERD 
aggregate total expenditure on R&D from the government as well as university, private enterprise, and not-
for-profit sector; yet this breakdown is rarely available for many African countries. The data available 
through internationally recognised and consistent sources on GERD for medical and health sciences is 
sparse (see Appendix 2, Table 4). The WHO African Barometer survey collects data on health research 
budgets, which is self-reported by health research focal points at Ministries of Health. Data from 2018 
reported that 24 countries have a dedicated budget line for health research and 37 countries regularly track 
health research spending from all sources.(89) Whilst this data shows a limited scope of HSciR funding, 
taking only the Ministry of Health budget and not other sources, it could contribute to better understanding 
of HSciR funding in countries. But this data has not been made publicly available by intergovernmental 
sources, and nor did we find centralised data on national research funds on the continent in any comparable 
way, but in-depth qualitative case studies in a sample of 9 African countries found these in 5 instances.(110) 
Future work evaluating HSciR could investigate which countries of the region have such funds, as there 
does not appear to be any data source indicating it at present despite a nascent literature on the topic.(111–
114) Similarly, when measuring the number of universities in each state, we were not able to ascertain 




Fifth, these metrics are all aggregated at the national level and thus this crude analysis fails to reveal any 
sub-national interaction. A more in-depth analysis could reveal particular “hubs” of excellence, as well as 
institutional capacity or individual capacities which form key components of the national landscape. 
5 Discursive Conclusion 
 
There has been a growing awareness of the importance of building health research systems in lower income 
settings over time. Whether it is to provide useful evidence to inform policy and health systems 
performance, to develop so-called ‘knowledge economies’ that support economic growth, or to ensure that 
there are research systems in place that can assist countries in responding to emergent and novel epidemic 
threats such as COVID-19. A range of stakeholders, including national governments, international donor 
agencies and global health policymaking bodies, may all be increasingly interested in ways to evaluate 
HSciR to guide future developments. We have sought to assess current capacity for HSciR across Africa, 
based on a subset of proxy indicators for which we had more complete data considering structural, process 
and output indicators. In doing so, we contribute to quantifying current strengths and lack of capacity in the 
HSciR landscape. Importantly, we didn’t find particular differential trends between these indicators. Some 
countries performed well across all three types of indicators, with variation amongst those performing less 
well as to where strengths lay – i.e. there were some locations which had stronger output indicators, but this 
didn’t necessarily correlate to strong process and structural drivers, and vice versa.  
Our findings have raised several issues for consideration:  
There are some unsurprising high performers across the variety of indicators, such as South Africa, Egypt 
and Tunisia, which score highly across most metrics. However, it is worth noting that it is not simply the 
level of development (GDP) or international or national financing for HSciR(GERD and international 
research funding) that leads to success in HSciR. Nations which have had major donor investment in HSciR 
(per capita), including Uganda and The Gambia, have not necessarily emerged as top performers across the 
range of proxy indicators used. Whilst current level of economic development does not appear to play a 
significant role in a country’s health sciences research capacity per se, our analysis shows clear correlation 
between GDP and a range of individual metrics (Appendix 2, although this is not evidence of causality). 
There are several possible explanations for these results. One explanation might be that reliance on donor 
funding has limited the sustainability of the health research sector when these collaborations end(115,116), 
or donor investment focused on projects which lacked significant improvements in broader infrastructures 
within the national system. Alternatively, international arrangements may result in research agendas set by 
the Global North, which could imply that they either reflect the needs of the funding location(117,118), a 
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focus on spotlight issues(119) or so-called ‘parachute research’(120,121) and bypass local research 
institutions and expertise (122), any of which may be limited in improving health research outcomes or 
capacity in the host location. The importance of local research development, however, has been highlighted 
as vital to building a knowledge economy and addressing domestic health concerns, as in-country 
researchers have the best understanding of the national agenda and cultural context which increased the 
likelihood of evidence uptake by policymakers.(22,123) Yet, it is clear that several African governments 
have not met the commitment to ensure 1% GDP is dedicated to research and many have struggled to make 
even minimal investments in HSciR from public finances, being more reliant on international donor or 
private.  
Another explanation is that using these indicators to measure performance does not capture the nuance of 
what is occurring within each system, particularly within each nation and the progress that research systems 
are making more holistically. For example, these metrics are not able to infer political commitment to 
HSciR, the relative importance of the HSciR landscape globally, how national systems have developed, 
where the success stories are and where barriers remain to solidifying knowledge economies. They are also 
unable to infer the historical contexts which led to the development of these systems, whether rooted in 
colonial science or post-colonial investments, each of which will lead to different looking HSciR 
environments.  
Moreover, there is a paucity of national data provided by governments across the African continent in the 
public domain. This was a notable gap and challenge for assessing the landscape of HSciR across the region. 
There may be few incentives in place to do so, but it would be important for governments to make more 
national level data available for future studies. This would allow future research to provide a realistic picture 
of HSciR within each nation and thus be able to make meaningful assessments of country capacity or areas 
for future investment. Our hope is that with this mapping exercise, whilst limited to global data sources, 
governments will be able to identify where their gaps in HSciR lie, or their perceived relative performance 
compared to regional counterparts. This  may offer meaningful analysis for investment priorities and future 
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